\begin{thebibliography}{10}

\bibitem{Huang11}
Huang Y, Gilbert PB.
\newblock Comparing biomarkers as principal surrogate endpoints.
\newblock \emph{Biometrics} 2011;\hspace{0pt}\textbf{67}(4):1442--1451.

\bibitem{Frangakis02}
Frangakis C, Rubin D.
\newblock Principal stratification in causal inference.
\newblock \emph{Biometrics} 2002;\hspace{0pt}\textbf{58}(1):21--29.

\bibitem{Taylor05}
Taylor JMG, Wang Y, ThiÂŽbaut R.
\newblock Counterfactual links to the proportion of treatment effect explained
  by a surrogate marker.
\newblock \emph{Biometrics} 2005;\hspace{0pt}\textbf{61}(4):1102--1111.

\bibitem{Follmann06}
Follmann D.
\newblock Augmented designs to assess immune response in vaccine trials.
\newblock \emph{Biometrics} 2006;\hspace{0pt}\textbf{62}(4):1161--1169.

\bibitem{Gilbert08}
Gilbert P, Hudgens M.
\newblock Evaluating candidate principal surrogate endpoints.
\newblock \emph{Biometrics} 2008;\hspace{0pt}\textbf{64}(4):1146--1154.

\bibitem{Wolfson10}
Wolfson J, Gilbert P.
\newblock Statistical identifiability and the surrogate endpoint problem, with
  application to vaccine trials.
\newblock \emph{Biometrics} 2010;\hspace{0pt}\textbf{66}(4):1153--1161.

\bibitem{Li10}
Li Y, Taylor JM, Elliott MR.
\newblock A {B}ayesian approach to surrogacy assessment using principal
  stratification in clinical trials.
\newblock \emph{Biometrics} 2010;\hspace{0pt}\textbf{66}(2):523--531.

\bibitem{Huang12}
Huang Y, Gilbert PB, Wolfson J.
\newblock Design and estimation for evaluating principal surrogate markers in
  vaccine trials.
\newblock \emph{Biometrics} 2013;\hspace{0pt}.

\bibitem{Zigler12}
Zigler C, Belin T.
\newblock A bayesian approach to improved estimation of causal effect
  predictiveness for a principal surrogate endpoint.
\newblock \emph{Biometrics} 2012;\hspace{0pt}\textbf{68}:922--932.

\bibitem{Gabriel13}
Gabriel E, Gilbert P.
\newblock Evaluating principal surrogate endpoints with time-to-event data
  accounting for time-varying treatment efficacy.
\newblock \emph{Biostatistics} 2013;\hspace{0pt}\textbf{In Press}.

\bibitem{Huang12b}
Huang Y, Gilbert PB, Janes H.
\newblock Assessing treatment-selection markers using a potential outcomes
  framework.
\newblock \emph{Biometrics} 2012;\hspace{0pt}\textbf{68}(3):687--96.

\bibitem{Hernan10}
Hern{\'a}n M.
\newblock The hazards of hazard ratios.
\newblock \emph{Epidemiology} 2010;\hspace{0pt}\textbf{21}(1).

\bibitem{Pepe91}
Pepe M, Fleming T.
\newblock A nonparametric method for dealing with mismeasured covariate data.
\newblock \emph{Journal of the American Statistical Association}
  1991;\hspace{0pt}\textbf{86}(413):108--113.

\bibitem{Heagerty99}
Heagerty P, Pepe M.
\newblock Semiparametric estimation of regression quantiles with application to
  standardizing weight for height and age in us children.
\newblock \emph{Journal of the Royal Statistical Society: Series C (Applied
  Statistics)} 1999;\hspace{0pt}\textbf{48}(4):533--551.

\bibitem{Heagerty00}
Heagerty PJ, Lumley T, Pepe MS.
\newblock Time-dependent {ROC} curves for censored survival data and a
  diagnostic marker.
\newblock \emph{Biometrics} 2000;\hspace{0pt}\textbf{56}(2):337--44.

\bibitem{DCCT}
DCCT/EDIC~Research G.
\newblock Intensive diabetes therapy and glomerular filtration rate in type 1
  diabetes.
\newblock \emph{The New England Journal of Medicine}
  2011;\hspace{0pt}\textbf{365}(25):2366--2376.

\bibitem{flemming96}
Fleming T, Demets D.
\newblock Surrogate end points in clinical trials: Are we being misled?
\newblock \emph{Annals of Internal Medicine}
  1996;\hspace{0pt}\textbf{125}(7):605--613.

\bibitem{Qin07}
Qin L, Gilbert P, Corey L, McElrath M, Self S.
\newblock A framework for assessing immunological correlates of protection in
  vaccine trials.
\newblock \emph{The Joutnal of Infectious Diseases}
  2007;\hspace{0pt}\textbf{196}(9):1304--1312.

\bibitem{Miao13}
Miao X, Li X, Gilbert P, \emph{et~al.}
\newblock Risk Assessment and Evaluation of Predictions, New York: Springer,
  volume 210 of \emph{Lecture Notes in Statistics / Lecture Notes in Statistics
  - Proceedings}, chapter A multiple imputation approach for surrogate marker
  evaluation in the principal stratification causal inference framework.
\newblock 2013;\hspace{0pt}.

\end{thebibliography}
